Chen Y, Liao S, Lai Y, Li Y, Lu Y, Tai C
Mol Med Rep. 2024; 31(3).
PMID: 39704209
PMC: 11683450.
DOI: 10.3892/mmr.2024.13421.
De Vleeschauwer S, van de Ven M, Oudin A, Debusschere K, Connor K, Byrne A
Nat Protoc. 2024; 19(9):2571-2596.
PMID: 38992214
DOI: 10.1038/s41596-024-00998-w.
Sellaeg K, Schwienbacher R, Kranz M, Aamodt A, Wirsing A, Berge G
Front Oncol. 2024; 14:1343839.
PMID: 38812785
PMC: 11133644.
DOI: 10.3389/fonc.2024.1343839.
Jang J, Lee B, Huang M, Seo C, Choi J, Shin Y
Mol Oncol. 2024; 18(8):1923-1939.
PMID: 38511232
PMC: 11306519.
DOI: 10.1002/1878-0261.13633.
Scemama A, Lunetto S, Tailor A, Di Cio S, Dibble M, Gautrot J
F1000Res. 2024; 12:439.
PMID: 38434654
PMC: 10904955.
DOI: 10.12688/f1000research.131810.2.
A scientometric study of chemical carcinogen-induced experimental oral carcinogenesis with emphasis on chemopreventive agents.
Zhou Z, Han X, Shen S, Sun K, Liu W
J Dent Sci. 2024; 19(1):614-619.
PMID: 38303894
PMC: 10829645.
DOI: 10.1016/j.jds.2023.06.004.
Towards system genetics analysis of head and neck squamous cell carcinoma using the mouse model, cellular platform, and clinical human data.
Zohud O, Lone I, Nashef A, Iraqi F
Animal Model Exp Med. 2023; 6(6):537-558.
PMID: 38129938
PMC: 10757216.
DOI: 10.1002/ame2.12367.
4-nitroquinoline 1-oxide induces immune cells death to onset early immunosuppression during oral squamous cell carcinoma development.
Sahu S, Thakur S, Peroumal D, Utkalaja B, Dutta A, Kumari P
Front Immunol. 2023; 14:1274519.
PMID: 37936711
PMC: 10626482.
DOI: 10.3389/fimmu.2023.1274519.
Oral squamous cell carcinomas: state of the field and emerging directions.
Tan Y, Wang Z, Xu M, Li B, Huang Z, Qin S
Int J Oral Sci. 2023; 15(1):44.
PMID: 37736748
PMC: 10517027.
DOI: 10.1038/s41368-023-00249-w.
Inducible TgfbR1 and Pten deletion in a model of tongue carcinogenesis and chemoprevention.
Lamenza F, Ryan N, Upadhaya P, Siddiqui A, Jordanides P, Springer A
Cancer Gene Ther. 2023; 30(8):1167-1177.
PMID: 37231058
PMC: 10754272.
DOI: 10.1038/s41417-023-00629-8.
Preclinical models in head and neck squamous cell carcinoma.
Chaves P, Garrido M, Oliver J, Perez-Ruiz E, Barragan I, Rueda-Dominguez A
Br J Cancer. 2023; 128(10):1819-1827.
PMID: 36765175
PMC: 10147614.
DOI: 10.1038/s41416-023-02186-1.
Development of a murine model of oral carcinogenesis: an accelerated tool for biomarker and anti-tumour drug discovery.
Syed S, Qureshi M, Khan S, Kumar R, Shafique Y, Khan B
Ecancermedicalscience. 2022; 16:1413.
PMID: 36072235
PMC: 9377819.
DOI: 10.3332/ecancer.2022.1413.
Fat and exposure to 4-nitroquinoline-1-oxide causes histologic and inflammatory changes in murine livers.
Pitstick L, Goral J, Schmelter R, Fuja C, Ciancio M, Pytynia M
PLoS One. 2022; 17(5):e0268891.
PMID: 35639668
PMC: 9154184.
DOI: 10.1371/journal.pone.0268891.
Long non-coding RNA LINC01296 promotes progression of oral squamous cell carcinoma through activating the MAPK/ERK signaling pathway via the miR-485-5p/PAK4 axis.
Zhang S, Wang X, Wang D
Arch Med Sci. 2022; 18(3):786-799.
PMID: 35591837
PMC: 9102572.
DOI: 10.5114/aoms.2019.86805.
Chemopreventive efficacy of salvianolic acid B phospholipid complex loaded nanoparticles against experimental oral carcinogenesis: implication of sustained drug release.
Liu W, Zhou Z, Zhu L, Li H, Wu L
Ann Transl Med. 2022; 10(5):244.
PMID: 35402586
PMC: 8987877.
DOI: 10.21037/atm-21-4457.
Long non-coding RNA LINC00472 inhibits oral squamous cell carcinoma via miR-4311/GNG7 axis.
Zou C, Lv X, Wei H, Wu S, Song J, Tang Z
Bioengineered. 2022; 13(3):6371-6382.
PMID: 35240924
PMC: 8974029.
DOI: 10.1080/21655979.2022.2040768.
BST2 promotes growth and induces gefitinib resistance in oral squamous cell carcinoma via regulating the EGFR pathway.
Jin H, Zhang L, Wang S, Qian L
Arch Med Sci. 2021; 17(6):1772-1782.
PMID: 34900059
PMC: 8641506.
DOI: 10.5114/aoms.2019.86183.
Extracellular ATP Induced S-Phase Cell Cycle Arrest via P2Y Receptor-Activated ERK Signaling in Poorly Differentiated Oral Squamous Cell Carcinoma SAS Cells.
Lau C, Aminuddin A, Chan K, Paterson I, Law L, Ng P
Life (Basel). 2021; 11(11).
PMID: 34833046
PMC: 8624497.
DOI: 10.3390/life11111170.
TNFα Signaling Is Increased in Progressing Oral Potentially Malignant Disorders and Regulates Malignant Transformation in an Oral Carcinogenesis Model.
Chadwick J, Macdonald R, Ali A, Glogauer M, Magalhaes M
Front Oncol. 2021; 11:741013.
PMID: 34650923
PMC: 8507421.
DOI: 10.3389/fonc.2021.741013.
Effector T cell responses unleashed by regulatory T cell ablation exacerbate oral squamous cell carcinoma.
Chao J, Korzinkin M, Zhavoronkov A, Ozerov I, Walker M, Higgins K
Cell Rep Med. 2021; 2(9):100399.
PMID: 34622236
PMC: 8484691.
DOI: 10.1016/j.xcrm.2021.100399.